Ovarian Cancer Trial, By Invitation NCT07058753 Sponsor: Medical University of Silesia Condition: Ovarian Cancer
Back to Ovarian Cancer

Ovarian Cancer Trial, By Invitation

NCT07058753
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been diagnosed with confirmed ovarian cancer
  • People whose doctors have determined that a certain type of upfront surgery (called primary debulking surgery) is not possible, based on a specific medical assessment score, and who have been referred for chemotherapy given before surgery
  • People who have agreed to take part in the study
  • People who are over 18 years of age

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who are having the upfront surgery to remove the tumour (primary debulking surgery)
  • People who have not agreed to take part in the study
  • People whose surgical assessment score (called the Aletti score) falls below a certain level at the time of surgery performed after chemotherapy (confirm with trial site)
  • People who have severe neurological or psychiatric conditions that make it difficult for the medical team to communicate with them

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
Medical University of Silesia
Registry
ClinicalTrials.gov
Start date
1 July 2025
Est. completion
1 July 2028

Where this trial is recruiting

🇵🇱 Poland

Primary endpoints

Frequency of postoperative complications; Length of hospital stay; Time to start adjuvant chemotherapy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov